back to top
Friday, July 11, 2025

Health

NSW Man Dies from Lyssavi...

A man in his 50s from northern New South Wales has died from Australian bat lyssavirus (ABLV), the state's first confirmed case. Health officials report the infection occurred months ago after a bat bite and emphasize that "there is no effective treatment" once symptoms manifest. This marks Australia's fourth ABLV-related death since its discovery in 1996.

Aromatic Benzaldehyde Sho...

Pancreatic cancer is extremely deadly due to its rapid resistance to treatments. Overcoming this resistance is crucial for better patient outcomes. Researchers in Japan discovered that aromatic benzaldehyde, a compound with an almond-like scent, can effectively inhibit therapy-resistant pancreatic cancer. Published in the British Journal of Cancer, their study shows that benzaldehyde disrupts vital protein interactions linked to treatment resistance and cancer cell adaptability. Preclinical studies indicate that it can make resistant cells more responsive to radiation and targeted therapies. Additionally, it prevents the epithelial-to-mesenchymal transition, a process that promotes cancer spread.

DR Congo Launches Initiat...

The Democratic Republic of the Congo (DRC) has launched a major five-year plan to combat HIV in children. President Félix Tshisekedi announced this initiative in Lualaba province, dedicating US $18 million to stop mother-to-child transmission, expand treatment for young people, and strengthen national health systems.Backed by the United Nations as "a beacon of hope" during global budget cuts, the initiative aims to align the DRC's domestic efforts with Sustainable Development Goal 3, targeting the end of the AIDS epidemic by 2030.

Exploring the Brain’s Res...

In a groundbreaking investigation into the biology of mental exhaustion, researchers at Johns Hopkins Medicine have identified key brain regions that light up when healthy adults push through feelings of cognitive fatigue. The study, published June 11 in the Journal of Neuroscience, employed functional MRI (fMRI) scans to track how volunteers’ brains react to increasingly demanding memory tasks—and how those reactions shape their decisions to continue or abandon effort.

Acid-Busting Vegan Diet O...

In a first-of-its-kind randomized crossover trial, researchers at the Physicians Committee for Responsible Medicine have demonstrated that a low-fat vegan diet dramatically lowers dietary acid load and delivers significant weight loss—13.2 pounds on average over 16 weeks—while a Mediterranean diet yields no appreciable change on the scale. The findings, published June 26 in Frontiers in Nutrition, underscore the inflammation-cooling, metabolism-boosting potential of an “alkalizing” plant-based regimen.

Vitamin C Revival: New St...

As we age, our body’s largest organ—our skin—undergoes profound changes. The epidermis, the outermost layer of the skin, steadily thins over time, compromising its essential role as a barrier against environmental assaults. Nearly 90 percent of the cells in this layer are keratinocytes, which originate deep within the epidermis before migrating upward to form the protective stratum corneum. Age-related declines in keratinocyte proliferation and differentiation leave the epidermis more fragile and less able to fend off pathogens, ultraviolet radiation, and physical damage.

ADC189: A Promising Singl...

Seasonal influenza continues to exact a heavy toll on global health, causing an estimated 3–5 million cases of severe illness and up to 650,000 respiratory deaths annually. Existing antivirals—principally neuraminidase inhibitors (such as oseltamivir) and M2 ion-channel blockers (amantadine and rimantadine)—have demonstrable limitations. Resistance to these agents has steadily increased, and their efficacy is often modest when administered more than 48 hours after symptom onset. Moreover, the logistical challenges of multi-dose regimens hinder public health efforts during epidemics and pandemics. There is therefore an urgent need for a novel, broadly active, single-dose antiviral that can both treat and prevent influenza, including resistant and pandemic strains.

Food Insecurity Tied to H...

Cancer survivors lacking access to nutritious food face higher death rates than those with secure food access, reveals new research from the University of Pennsylvania Perelman School of Medicine. Published in JAMA Health Forum, this study is the first large-scale analysis connecting food insecurity to survival outcomes in cancer patients. With nearly 18 million cancer survivors in the U.S., these findings highlight the critical need to include social health factors, especially access to healthy food, in cancer care.

Why a Mosquito Researcher...

Dr Véronique Paris, a medical entomologist at the University of Melbourne, takes an unorthodox approach to studying mosquito-borne diseases: she feeds live mosquitoes on her own blood. In weekly lab sessions, she slides her bare arm into a mesh enclosure housing hundreds of mosquitoes—allowing them to bite her in order to maintain healthy colonies and collect eggs for experiments. Her hands-on method may seem extreme, but it has become an essential component of her efforts to understand and curb the spread of pathogens such as the flesh-eating Buruli ulcer.

Measles Alert Issued in S...

Health officials in New South Wales have issued a measles alert after a contagious traveler passed through Sydney International Airport. This case, linked to flight VN773 from Southeast Asia, highlights a worrying increase in measles cases worldwide. People who were in the arrivals and baggage claim areas between 8:00 am and 9:30 am on the flight day should watch for symptoms and check their vaccination status right away.

One in Three in the UK Ov...

Since the COVID-19 pandemic began, cervical cancer screening rates in England have fallen from 72.2 percent in 2020 to 68.4 percent in 2024, NHS England data shows. A recent YouGov survey of 3,000 eligible individuals—commissioned by Cancer Research UK—finds that 30 percent of respondents are now overdue for their routine cervical screening. Experts warn that this sustained decline poses a serious obstacle to the NHS’s pledge to eliminate cervical cancer by 2040.